VAERS reports by lot

GSK Varicella/Shingles lot 9277N: VAERS reports

49 VAERS reports list lot 9277N as a GSK Varicella/Shingles vaccine, received between 2019-01-18 and 2020-08-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
49
Reports
6%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4523%
Injection-site / Local reaction4020%
Musculoskeletal3216%
Neurological2312%
Dermatological (non-injection-site)1910%
Cardiac / Cardiovascular116%
Psychiatric / Neuropsychiatric84%
Respiratory74%
Gastrointestinal74%
Allergic / Anaphylactic42%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York10
New Jersey3
California3
Illinois3
Pennsylvania3
Oregon3
Texas3
Ohio2
Indiana2
Michigan2
Florida2
Nevada1

Reports by month received

2019-017
2019-0216
2019-0312
2019-044
2019-052
2019-064
2019-071
2019-091
2019-111
2020-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.